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The development of a serological test for foot-and-mouth disease virus (FMDV) which is quick and easy to
use, which can identify all seven serotypes, and which can differentiate vaccinated from convalescing or
potential virus carriers would be a major advance in the epidemiological toolkit for FMDV. The nonstructural
polyprotein 3ABC has recently been proposed as such an antigen, and a number of diagnostic tests are being
developed. This paper evaluates the performance of two FMDV tests for antibodies to nonstructural proteins
in an unvaccinated cattle population from a region of Cameroon with endemic multiple-serotype FMD. The
CHEKIT-FMD-3ABC bo-ov (CHEKIT) enzyme-linked immunosorbent assay (ELISA) (Bommeli Diagnostics/
Intervet) is a commercially available test that was compared with a competitive 3ABC ELISA (C-ELISA)
developed in Denmark. The tests were compared with the virus neutralization test as the “gold standard.”
Diagnostic sensitivity and specificity were examined over a range of test cutoffs by using receiver operating
characteristic curves, which allowed comparison of the overall performance of each test. The results indicated
that the CHEKIT ELISA kit was 23% sensitive and 98% specific and the Danish C-ELISA was 71% sensitive
and 90% specific at the recommended cutoff. These results have important implications if the tests are to be
used to screen herds or individual cattle in surveillance programs, at border crossings for import-export
clearance, or following emergency vaccination in an outbreak situation.
Foot-and-mouth disease (FMD) is a highly contagious viral
disease of even-toed ungulates caused by Foot-and-mouth dis-
ease virus (FMDV), which is a member of the genus Aphtho-
virus and the family Picornaviridae (25). FMDV is a small
nonenveloped virus with an 8.5-kbp genome which codes for
structural as well as nonstructural proteins (NSPs) (11, 18).
There are seven serotypes, known as serotypes O, A, C, SAT 1,
SAT 2, SAT 3, and Asia 1, recognized worldwide. All of these
occur in Africa except Asia 1 (43). These serotypes are clini-
cally indistinguishable, and there may be considerable varia-
tion in the disease presentation depending on the strain within
a serotype, the species affected, and previous exposure (26, 27,
29). It is one of the most important economic diseases of
livestock owing to both the production losses caused by clinical
disease and the disruption caused in international trade with
disease-free countries.
The two principal control strategies for FMD are stamping
out and vaccination, which may be used either prophylactically
or as an emergency campaign during an outbreak. In May 2002
the Office International des Epizooties (OIE) updated its In-
ternational Animal Health Code in light of advances in diag-
nostic tests, allowing countries that vaccinate in the face of an
outbreak of FMD to regain disease-free status after 6 months
if they can differentiate vaccinated from infected or convalesc-
ing animals. Differentiation of convalescing or infected animals
is based on identifying antibodies to the NSPs of FMDV (2, 15,
39, 40).
The NSPs are expressed only by replicating viruses. Inacti-
vated vaccines are purified to remove cellular proteins and
NSPs, and therefore only animals that have been infected with
live virus should develop antibodies to these proteins (2, 4, 35).
Currently, the polyproteins 3ABC and 3AB appear to be most
promising as diagnostic antigens (6, 15, 30, 37, 41). They have
been expressed as fusion proteins in Escherichia coli (30) and
baculovirus vectors in insect cells (34, 41) used in a variety of
assays, including agar gel immunodiffusion (33), latex aggluti-
nation (42), immunoelectrotransfer blot analysis (3), and direct
and blocking enzyme-linked immunosorbent assays (ELISAs)
(30, 39).
As these tests will be used in the regulation of trade in live
animals and their products, their evaluation in a range of
populations is essential since diagnostic sensitivity (Se) and
specificity (Sp) are parameters that describe test performance
for a given reference population (21).
Here we describe a comparison of two NSP tests, the
CHEKIT-FMD-3ABC bo-ov (CHEKIT) ELISA (Bommeli
Diagnostics/Intervet), which is a commercially available test,
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and an experimental competitive ELISA (C-ELISA) devel-
oped in Denmark (39), in an unvaccinated cattle population
and using a combined virus neutralization test (cVNT) result
as the “gold standard.”
MATERIALS AND METHODS
Study population. A full description of the study area, the livestock popula-
tion, and the study design is given elsewhere (9). In brief, a population-based
sample of herds was selected from the Adamawa Province of Cameroon by use
of a sample frame constructed from the government’s rinderpest vaccination lists
which were maintained at each of the 88 local veterinary centers. A total of
13,006 herds were included in the database, and a two-stage random sample of
herds was selected assuming a herd-level prevalence of 50%. The first stage was
a random sample of veterinary centers (with replacement), with the probability
of selection proportional to the number of herds registered at the center, and the
second stage was a random sample of three herds per center (without replace-
ment). The herd sample size was calculated using the Survey Toolbox software
(A. R. Cameron, Wentworth Falls, New South Wales, Australia), and a total of
162 herds in 54 veterinary centers were selected.
Within herds a stratified sample of five juvenile (8- to 24-month-old) and five
adult (24-month-old) cattle was randomly selected. This allowed 95% confi-
dence of identifying at least one seropositive animal in a herd of 70 cattle with
a seroprevalence of 50% (10).
Collection of samples. Cattle were cast in lateral recumbency and examined
for lesions, and a serum sample and an oropharyngeal fluid or probang (OP)
sample were taken. Blood samples were allowed to clot and were then centri-
fuged at 1,100  g for 10 min in the field by use of a Mobilespin 12-V field
centrifuge (Vulcon Technologies) or a hand-cranked centrifuge (OFI Testing
Equipment, Inc.). Approximately 3.5 ml of serum was aliquoted into two 1.8-ml
cryovials (Nunc) and kept at 4°C in a portable gas refrigerator until they could be
frozen and stored at 20°C. The OP samples were stored in liquid nitrogen at
the end of each day’s sampling. The serum and OP samples were transferred to
the FMD World Reference Laboratory (WRL) on dry ice or liquid nitrogen,
where they were stored at 20°C and 70°C, respectively. Data collected by
questionnaire indicated that no herdsman reported using an FMDV vaccine and
no government licenses had been issued for import of vaccines into the country;
therefore, the population was believed to be unvaccinated. The study was con-
ducted between April and October 2000, which encompasses the rainy season,
when herds are close to their home areas.
Tissue culture of OP samples. A 0.2-ml sample of each OP sample was
inoculated onto five bovine thyroid cell monolayers (38) and incubated at 37°C
for up to 72 h on rollers, following the OIE/WRL protocol (28). The cultures
were examined daily for any signs of cytopathic effect. Cultures with a positive
cytopathic effect were then typed using the WRL sandwich antigen ELISA (17,
28, 36). Of 38 samples that were positive, 20 were serotype A and 18 were
serotype SAT 2. In a separate study of pigs, serotype O was isolated from clinical
samples and may have been present in the cattle population, but no probang
samples were positive during the sampling for the cross-sectional study.
VNT. Virus isolation from probang samples indicated that the FMDV sero-
types A and SAT 2 were actively circulating in the cattle population and that
serotype O was actively circulating in the swine population at the time of the
cross-sectional study. VNTs were carried out for these three serotypes following
OIE/WRL protocol (20, 28). Serum samples were heat inactivated (56°C, 30
min), and neutralizing antibodies were assessed against FMDV type O Manisa
and homologous Cameroon isolates of type A (P59/2000-VBM/153/09) and type
SAT 2 (P26/2000-FDL/74/10). Duplicate, doubling dilutions of serum samples
were tested. The end point for 100 50% tissue culture infective doses was
estimated for each sample (24), and the standard OIE cutoff dilution, 1/101.56
(1:45), was used. Control dilutions of the virus and reference sera were carried
out, and in cases where the control dilutions were out of range, the entire test was
repeated. For each batch of VNTs, the viral dose used was calculated from
control plates, and the batch was rejected if the control doses were outside the
control range of 100  100.5 50% tissue culture infective doses. Similarly, the
working titer of the control sera was calculated for each batch, and if the titer
differed by more than 100.3 of the running mean, the batch was retested. The
results of the three VNTs were combined such that an animal that was positive
for one or more serotypes was classed as positive for the cVNT.
CHEKIT ELISA. The CHEKIT ELISA was used according to the manufac-
turer’s instructions. Briefly, the serum was diluted 1/100, added in duplicate to
the wells of a 96-well microtiter plate precoated with the vector-expressed viral
3ABC antigen, and incubated for 60 min at 37°C in a humid chamber. Unbound
antibody was washed away, and a horseradish peroxidase-labeled guinea pig
anti-bovine immunoglobulin G conjugate was added. Unbound conjugate was
removed by washing, and the chromogen substrate was added and incubated
until the difference in the optical density (OD) reading between the negative and
positive controls was 0.4 (after about 20 min). The OD was determined for
each well at 405 nm with an automatic plate reader. The final OD value for the
sample was expressed as a percentage of the OD of the positive control by using
the mean OD of each pair of samples (ODsample) and the median OD of the four
positive and negative controls (ODpositive and ODnegative, respectively) on each
plate in the following formula: final OD  [(ODsample  ODnegative)/(ODpositive
 ODnegative)]  100.
The manufacturer’s recommended interpretation was that a final OD value of
20% is negative, one of 20 to 30% is ambiguous, and one of 30% is positive.
C-ELISA. The C-ELISA was performed as described previously (41), with
modifications. The original samples were aliquoted, heat treated at 56°C for 2 h,
and then shipped to Denmark for testing. Microtiter plates were prepared by
capturing 3ABC protein produced in a baculovirus expression system with a
monoclonal antibody (MabL74D5) coated on the plates. Dilutions (1:5) of the
sera were added, the plates were incubated overnight at 37°C and washed, and
the competing antibody, horseradish peroxidase-conjugated monoclonal anti-
body MabL74D5, was added; the plates were then incubated for another hour at
37°C. After washing the plates and adding chromogen substrate (tetramethyl-
benzidine and H2O2), the color development (OD) was measured after 15 min
at 450 nm, and the results were expressed as a percentage of the negative control
values determined by the following: OD  (ODsample/ODmean negative controls) 
100. The recommended cutoff is 50% for a positive result.
Statistical analysis. The cVNT and ELISA results were first compared at the
individual animal level in 2  2 tables. The Se and Sp of each test were calculated
using the recommended cutoffs of 30% for the CHEKIT ELISA and50% for
the C-ELISA. The test characteristics were further investigated by use of the
receiver operating characteristic (ROC) curves calculated with AccuROC ver-
sion 2.4 (Accumetric). The ROC curve is drawn by calculating the Se and Sp for
all possible cutoff values of the test and then plotting the Se against 1 minus the
Sp (i.e., the probability of detecting a true positive result against the probability
of a false positive result). The area under the curve (AUC) then represents the
overall performance of the test with a maximum area of 1 for a test with perfect
Se and Sp. The AUC was calculated for each test using the nonparametric
method of DeLong et al. (16), and these values were then compared using a Z
statistic and a two-tailed test which is available within the package. Based on the
recommended cutoff values of the tests, the Se and Sp of the CHEKIT ELISA
and the C-ELISA were estimated. Furthermore, kappa values were calculated to
assess the agreement between the two tests (19).
The herd-level sensitivity (HSe; the conditional probability that a herd will test
positive given that it is diseased) and the herd-level specificity (HSp; the condi-
tional probability that a herd will test negative given that the herd is not diseased)
of the two tests were examined over a range of possible within-herd prevalences
by using Herdacc version 3.0 software (D. Jordan, University of Guelph, Guelph,
Canada) with a theoretical herd of 100 animals. A herd would be categorized as
positive if one animal in the sample from the herd was positive. The HSp and
HSe are calculated from the formulae in equations 1 and 2 (32), which are shown
below. It is important to note that the HSp is related only to the individual test
Sp and the sample size, while the HSe is related to the individual test Se and Sp,
the sample size, and importantly, the true prevalence of disease in the herd.
HSp Spn (1)
HSe 1 	1 
1 Sp Se Sp 1TPn 1 1 APn (2)
where n is the sample size, TP is the true disease prevalence in the herd, and AP
is the apparent prevalence, i.e., the proportion of test positives, in the population.
RESULTS
Comparison of the C-ELISA and CHEKIT ELISA with the
cVNT in adults and juveniles. The estimates of the Se and Sp
of the C-ELISA and CHEKIT ELISA for all animals are given
in Table 1. The results show that the C-ELISA has low relative
Se (71%) and Sp (90%) at the recommended cutoff. In com-
parison, the Se of the CHEKIT ELISA is extremely low (23%)
at the recommended cutoff of 30%, although the Sp is very
high (98%).
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The test cutoffs were examined by using the ROC curves
shown in Fig. 1. It is clear from Fig. 1 that the C-ELISA
performs better overall and that this result was statistically
significant (P  0.01). The CHEKIT ELISA, though not per-
forming as well overall, is not optimized at the cutoff of 30%,
which lies in the vertical part of the curve in the lower left of
the plot. The cutoff could be lowered significantly with very
little loss of Sp.
Comparison of the C-ELISA and CHEKIT ELISA with the
VNT in juvenile animals. The analysis of Se and Sp of the
C-ELISA and the CHEKIT ELISA was repeated for the subset
of juvenile animals (8 to 24 months old) in an effort to inves-
tigate whether using animals that had been infected only in the
last 2 years would improve the estimates, as suggested by
Bergmann et al. (3). As shown in Table 2, there was no im-
provement in the test performance. The CHEKIT ELISA Se
dropped to 15% while the Sp did not change, and for the
C-ELISA the Se dropped to 57% although the Sp increased
slightly, to 94%. The changes in test parameters are reflected
in the ROC curves with the AUC decreasing for both tests,
although the C-ELISA still performed better than the
CHEKIT ELISA (Fig. 2).
Comparison of test results for probang-positive animals. In
order to investigate the Se of the tests for carrier animals, the
ELISA results for the 38 animals that had a positive probang
result (after FMDV was cultured and typed) were examined.
The ELISA test results were plotted against the number of
months since the last outbreak of FMD in the herd reported by
the herdsman (Fig. 3). In this study most carrier animals came
from herds with FMD reported in the previous 12 months. The
range of OD percentage values recorded for each of the two
tests varied, with a more clustered pattern well below the test
cutoff value for the C-ELISA and a more dispersed range of
readings straddling the cutoff for the CHEKIT ELISA. The
C-ELISA detected 35 of 38 (92%) positive animals, while the
CHEKIT ELISA detected only 18 of 38 (47%).
Implications of using the CHEKIT ELISA and C-ELISA at
a herd level. In order to demonstrate the effect of using these
TABLE 1. Estimates of Se and Sp for the CHEKIT ELISA and the
C-ELISA compared to the cVNT as a gold standarda
cVNT result CHEKIT result
No. of animals with
C-ELISA result that
was:
 
Seropositiveb  205 7
 443 252
Seronegativec  6 4
 41 419
a Total number of animals tested, 1,377. The recommended cutoffs of 30% for
the CHEKIT ELISA and 50% for the C-ELISA were used.
b Se of CHEKIT ELISA  0.234; Se of C-ELISA  0.714; kappa value of
0.192 between CHEKIT and C-ELISA results.
c Sp of CHEKIT ELISA  0.979; Sp of C-ELISA  0.900; kappa value of
0.182 between CHEKIT and C-ELISA results.
FIG. 1. ROC curves for 3ABC CHEKIT ELISA (AUC  0.782)
and C-ELISA (AUC  0.865) for adult and juvenile animals (n 
1,377). Two-tailed test of AUC Z statistic  5.217; P  0.01. Arrows
mark the recommended cutoffs for each test.
TABLE 2. Estimates of Se and Sp for the CHEKIT ELISA and the
C-ELISA based on subset of juvenile animals and compared to the
cVNT as the gold standarda
cVNT result CHEKIT result
No. of animals with
C-ELISA result that
was:
 
Seropositiveb  46 2
 136 134
Seronegativec  2 4
 17 310
a Total number of animals tested, 651. The recommended cutoffs of 30% for
the CHEKIT ELISA and 50% for the C-ELISA were used.
b Se of CHEKIT ELISA  0.151; Se of C-ELISA  0.572; kappa value of
0.212 between CHEKIT and C-ELISA results.
c Sp of CHEKIT ELISA  0.982; Sp of C-ELISA  0.942; kappa value of
0.136 between CHEKIT and C-ELISA results.
FIG. 2. ROC curves for CHEKIT ELISA (AUC  0.707) and
C-ELISA (AUC  0.829) based on juveniles only (n  651). Two-
tailed test of AUC Z statistic  4.64; P  0.01.
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tests at the herd level, the two tests were applied to a theoret-
ical herd of 100 cattle with a range of prevalences of 0 to 30%.
The probability of correctly identifying a herd as infected, i.e.,
the HSe, increases with true prevalence and sample size (Ta-
bles 3 and 4). For the CHEKIT ELISA (Table 3), the only
commercially available test, the HSe is 9.8% at a prevalence of
1% with a sample size of 5 cattle, while the HSe is 99.9% with
a sample size of 55 cattle from a herd with a prevalence of
FIG. 3. Scatter plots of the OD readings for the CHEKIT ELISA (, 30%) and C-ELISA (,50%) plotted against the number of months since
the herdsman reported the last outbreak of FMD for animals that were probang culture positive (n  38). Cutoffs are marked with horizontal lines.
TABLE 3. HSe and HSp of the CHEKIT ELISAa
No. of animals
tested HSp (0, 2)
b
HSe for herd with indicated characteristics
1, 2b 5, 3 10, 4 20, 6 30, 8
5 0.902 0.098 0.144 0.188 0.271 0.347
15 0.721 0.279 0.389 0.484 0.633 0.741
25 0.561 0.439 0.582 0.690 0.831 0.909
35 0.420 0.580 0.730 0.827 0.931 0.973
45 0.300 0.700 0.838 0.913 0.976 0.993
55 0.200 0.800 0.912 0.962 0.993 0.999
a Assumptions: cutoff point, 1; Se, 0.23; Sp, 0.98. Sampling without replace-
ment. Herd size, 100 animals. Hypergeometric distribution used.
b Number of infected animals in herd, number of test positives in herd.
TABLE 4. HSe and HSp of the C-ELISAa
No. of animals
tested HSp (0, 10)
b
HSe for herd with indicated characteristics
1, 11b 5, 13 10, 16 20, 22 30, 28
5 0.584 0.449 0.509 0.590 0.720 0.814
15 0.181 0.849 0.896 0.942 0.983 0.995
25 0.048 0.965 0.982 0.994 0.999 1.000
35 0.010 0.994 0.998 1.000 1.000 1.000
45 0.002 0.999 1.000 1.000 1.000 1.000
55 0.000 1.000 1.000 1.000 1.000 1.000
a Assumptions: cutoff point, 1; Se, 0.71; Sp, 0.9. Sampling without replacement.
Herd size, 100 animals. Hypergeometric distribution used.
b Number of infected animals in herd, number of test positives in herd.
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30%. This higher probability would be achieved with a sample
size of about 15 cattle with the C-ELISA (Table 4). In contrast,
the probability of correctly classifying a negative herd (HSp)
declines with an increasing sample size. For the CHEKIT
ELISA, this probability declines from 90.2% with a sample size
of 5 to 20% with a sample size of 55. Because of the poorer test
Sp, this decline in HSp is a greater problem with the C-ELISA.
DISCUSSION
Serological tests which differentiate FMDV-vaccinated ani-
mals from unvaccinated, exposed animals that are either re-
covering or that are persistently infected could be used (i) for
herd surveillance following emergency vaccination in a disease-
free country after an outbreak or as part of an eradication
program in a country where the disease is endemic or (ii) to
screen individuals or groups of animals at import-export sta-
tions. An added advantage of the NSP tests is that a single test
can be used to detect antibodies to any of the seven serotypes
of FMDV. Our original intention was to use the CHEKIT
ELISA to classify the herds in this unvaccinated cattle popu-
lation as having been exposed or not exposed to FMDV. This
would have avoided the need to perform multiple, time-con-
suming VNTs.
The comparison of the two NSP ELISAs with the cVNT as
the gold standard indicates that the CHEKIT ELISA has very
high Sp (98%) but very low Se (23% for adults and juveniles or
15% for juveniles only). No previous publications mention this
kit, although several studies used a similar format with an E.
coli-expressed protein. The parameter estimates were high,
with an Se of 100% and an Sp of 99% in cattle 20 days
postinfection (31) and an Se of 92% and an Sp of 90% in sheep
(7). However, these studies were based on small, experimen-
tally infected groups rather than naturally infected popula-
tions. The problem with this test population is that the test is
then not being implemented against the range of disease stages
likely to be encountered in the field. In comparison, the results
of the present study were based on a population sample from
naturally infected cattle.
The Danish 3ABC C-ELISA had much higher Se but lower
Sp. This test has been used more widely in both a 3AB and a
3ABC format. In Chinese cattle in Taiwan, the parameters for
the 3AB format were estimated to be an Se of 64% and an Sp
of 99% (22). In pigs, also in Taiwan, the estimates were an Se
of 73% and an Sp of 90% (13), although in a later communi-
cation they were revised to be an Se of 96% and an Sp of 99%
(12). The 3ABC format was used in a small sample of exper-
imentally infected cattle (n  58), and the estimates were an Se
of 88% and an Sp of 99.8% (41). These estimates compare with
an Sp of 90 to 94% and an Se of 57 to 71% in the present study.
There may be several reasons for this difference. There may be
nonspecific cross-reactions with other pathogens or antigens to
which animals are exposed in the tropics or differences be-
tween breeds and management systems (21). It has also been
suggested that tests based on these long recombinant proteins
may cross-react with antibodies to the system in which they
were produced, such as insect proteins. Using peptides for
specific epitopes may help overcome this problem (37).
Se and Sp are not fixed values and will differ between sub-
populations and between populations depending on the distri-
bution of influential covariates (e.g., age and stage of disease).
It has been suggested that the 3ABC test be used with young
animals during surveillance (3); however, our results suggest
that in fact there is a lower relative Se in the juvenile popula-
tion for both of these tests. The CHEKIT ELISA had a par-
ticularly low Se of 15% in this age group. Therefore an even
greater risk of failing to identify seropositive animals would
exist if only juveniles were selected.
VNTs were used as the gold standard in this comparison,
using three (O, A, and SAT 2) of the six serotypes likely to
occur in Africa. These three were selected because they were
the only serotypes isolated from the population. SAT 1 has
never been identified in Cameroon, although its presence has
been recorded in neighboring Nigeria, and serotypes SAT 3
and C were unlikely to occur in this region (43). Previous
studies have suggested that the antibody response to the 3ABC
proteins occurs slightly later than the VN response to the
structural proteins (41) and that the 3ABC antibodies may not
persist for as long as the VN antibodies. The estimates range
from only a few months (8) up to 3.5 years (13) for the 3ABC
antibodies, compared to 1 to 3 years (1) up to 4.5 years (14) for
the VN antibodies. Therefore, comparing the 3ABC ELISAs
with the cVNT is likely to produce a low Se estimate if the
durations of the antibody response are different. Another ap-
proach would be to compare the NSP tests using a model
without a gold standard (23). Both maximum likelihood and
Bayesian approaches are being investigated, and the results of
this investigation will be presented in a technical statistical
paper.
The problems of these tests at the level of the individual
animal change when the tests are used to classify herds as
positive or negative. Poor individual test Se can be improved by
increasing the sample size, although the very poor Se of the
CHEKIT ELISA will never be overcome unless the true herd
prevalence is very high. However, one of the suggested roles
for these tests is to differentiate vaccinated from exposed or
carrier animals following an outbreak and emergency vaccina-
tion program. If vaccination has been successful and transmis-
sion has been reduced, it is likely that the prevalence of ex-
posed and carrier animals within a herd will be very low. Even
with perfect test Sp, the CHEKIT ELISA would not be able to
detect herds with low prevalences, although the C-ELISA
would perform much better. However, because the Sp is less
than perfect for both tests, there is in fact a counterintuitive
increase in HSe due to the false positives. The C-ELISA has
much better HSe for a given true prevalence, but the cost will
be many more false-positive herds that will need to be retested
with another, more specific test. While this requirement may
protect an importing country, it would be a major problem for
an exporting country. In particular, the increasing problem of
false positives can be combated by altering the cutoff number
of positives or by using a second, more specific test. The cur-
rent recommendation by the OIE is a combination of a 3ABC
ELISA and a subsequent enzyme-linked immunoelectrotrans-
fer blot assay to confirm all positives (6). Such an approach has
been used successfully in South America, where vaccination
has been used for eradication (5).
In situations in areas of endemicity at the start of an erad-
ication program, the C-ELISA will clearly be the better test to
use since the sample sizes will be smaller and the problem of
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false positives will be reduced. However, as the prevalence
declines, the same problems will arise as previously discussed,
and the strategy may need to be adjusted accordingly. In terms
of screening import-export animals, the CHEKIT ELISA is
likely to be of use only to exporters needing to declare animals
seronegative since the test has such a low Se. The C-ELISA, in
contrast, will have problems with many false positives. The
tests should not be used or interpreted on a herd basis unless
the animals constitute a complete herd or epidemiological
group, which in many import-export situations is not the case.
It would, however, be useful to model the different situations
and costs of the different tests in order to identify the most
efficient strategies for each situation.
The main hope for these 3ABC tests is that they will help to
identify carrier animals and subclinical infections in a vacci-
nated population during the surveillance phase after an out-
break or that they can be used during an eradication based on
vaccination to monitor areas with continuing transmission.
However, in the present study only 47% of carrier animals
(those that showed no clinical signs at the time of sampling but
yielded probang samples that were FMDV positive) were de-
tected by the commercial test. The C-ELISA performed better
but still failed to detect 8% (3 of 38) of probang-positive
animals. One of these animals may have been at a very early
stage of infection, while it had been several years since the last
reported infection for another. In both cases the titers might be
expected to be low. Although the present study was carried out
with an unvaccinated population, the tests need to be able to
detect seropositive animals that are carriers or subclinically
infected regardless of whether the animals had been vacci-
nated; if the tests fail to detect these exposed seropositive
populations, the issue of differentiating them from vaccinated
animals becomes meaningless. Clearly, however, it would be
useful to have a vaccinated exposed population with which to
compare these results.
The recent changes in OIE regulations will allow countries
to resume trading after 6 instead of 12 months if the animals
are vaccinated and can then be screened and demonstrated to
be free from disease. While this change will facilitate trade in
line with the current World Trade Organization agreements, it
requires a test that will distinguish vaccinated from subclini-
cally infected or convalescing animals. This study does not
address the difficulties of differentiating vaccinated animals but
highlights the problems of detecting infected animals and
herds. It shows that both the commercially available CHEKIT
ELISA and the C-ELISA have problems at the level of the
individual animal. Some of these problems can be overcome by
using the tests at the herd level. This study demonstrates the
importance of evaluating these tests at the population level in
an environment in which they will be used. This requirement is
essential in ensuring that commercial pressures do not com-
promise international animal health.
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